{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T19:15:19Z","timestamp":1785352519398,"version":"3.55.0"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,6,23]],"date-time":"2022-06-23T00:00:00Z","timestamp":1655942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,23]],"date-time":"2022-06-23T00:00:00Z","timestamp":1655942400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Metastasis"],"published-print":{"date-parts":[[2022,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>For peritoneal metastases (PM), there are few curative treatment options, and they are only available for a select patient group. Recently, new therapies have been developed to deliver intraperitoneal chemotherapy for a prolonged period, suitable for a larger patient group. These drug delivery systems (DDSs) seem promising in the experimental setting. Many types of DDSs have been explored in a variety of animal models, using different cytostatics. This review aimed to provide an overview of animal studies using DDSs containing cytostatics for the treatment of gastro-intestinal PM and identify the most promising therapeutic combinations. The review was conducted following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines and Systematic Review Center for Laboratory Animal Experimentation (SYRCLE) guidelines. The 35 studies included revealed similar results: using a cytostatic-loaded DDS to treat PM resulted in a higher median survival time (MST) and a lower intraperitoneal tumor load compared to no treatment or treatment with a \u2018free\u2019 cytostatic or an unloaded DDS. In 65% of the studies, the MST was significantly longer and in 24% the tumor load was significantly lower in the animals treated with cytostatic-loaded DDS. The large variety of experimental setups made it impossible to identify the most promising DDS-cytostatic combination. In most studies, the risk of bias was unclear due to poor reporting. Future studies should focus more on improving the clinical relevance of the experiments, standardizing the experimental study setup, and improving their methodological quality and reporting.<\/jats:p>","DOI":"10.1007\/s10585-022-10173-8","type":"journal-article","created":{"date-parts":[[2022,6,23]],"date-time":"2022-06-23T09:02:31Z","timestamp":1655974951000},"page":"541-579","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Intraperitoneal drug delivery systems releasing cytostatic agents to target gastro-intestinal peritoneal metastases in laboratory animals: a systematic review"],"prefix":"10.1007","volume":"39","author":[{"given":"Anne G. W. E.","family":"Wintjens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geert A.","family":"Simkens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter-Paul K. H.","family":"Fransen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narcis","family":"Serafras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaatje","family":"Lenaerts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregor H. L. M.","family":"Franssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignace H. J. T.","family":"de Hingh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia Y. W.","family":"Dankers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole D.","family":"Bouvy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Peeters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,23]]},"reference":[{"key":"10173_CR1","unstructured":"Desai JP, Moustarah F (2019) Cancer, Peritoneal Metastasis. StatPearls [Internet]"},{"issue":"5","key":"10173_CR2","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1016\/j.ejso.2020.11.135","volume":"47","author":"RJ Lurvink","year":"2021","unstructured":"Lurvink RJ, Bakkers C, Rijken A, van Erning FN, Nienhuijs SW, Burger JW et al (2021) Increase in the incidence of synchronous and metachronous peritoneal metastases in patients with colorectal cancer: a nationwide study. Eur J Surg Oncol 47(5):1026\u20131033","journal-title":"Eur J Surg Oncol"},{"issue":"12","key":"10173_CR3","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1046\/j.1365-2168.2002.02274.x","volume":"89","author":"DG Jayne","year":"2002","unstructured":"Jayne DG, Fook S, Loi C, Seow-Choen F (2002) Peritoneal carcinomatosis from colorectal cancer. Br J Surg 89(12):1545\u20131550","journal-title":"Br J Surg"},{"issue":"3","key":"10173_CR4","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1002\/ijc.28373","volume":"134","author":"I Thomassen","year":"2014","unstructured":"Thomassen I, van Gestel YR, van Ramshorst B, Luyer MD, Bosscha K, Nienhuijs SW et al (2014) Peritoneal carcinomatosis of gastric origin: a population-based study on incidence, survival and risk factors. Int J Cancer 134(3):622\u2013628","journal-title":"Int J Cancer"},{"issue":"1","key":"10173_CR5","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1097\/MPA.0b013e31825abf8c","volume":"42","author":"I Thomassen","year":"2013","unstructured":"Thomassen I, Lemmens VE, Nienhuijs SW, Luyer MD, Klaver YL, de Hingh IH (2013) Incidence, prognosis, and possible treatment strategies of peritoneal carcinomatosis of pancreatic origin: a population-based study. Pancreas 42(1):72\u201375","journal-title":"Pancreas"},{"issue":"6","key":"10173_CR6","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1097\/MPA.0000000000001857","volume":"50","author":"A Rijken","year":"2021","unstructured":"Rijken A, Bakkers C, van Erning FN, van der Geest LG, de Vos-Geelen J, Besselink MG et al (2021) Incidence, treatment, and survival of synchronous peritoneal metastases in pancreatic cancer: update of a nationwide cohort. Pancreas 50(6):827\u2013833","journal-title":"Pancreas"},{"issue":"21","key":"10173_CR7","doi-asserted-by":"publisher","first-page":"4882","DOI":"10.3390\/jcm10214882","volume":"10","author":"A Rijken","year":"2021","unstructured":"Rijken A, Lurvink RJ, Luyer MDP, Nieuwenhuijzen GAP, van Erning FN, van Sandick JW et al (2021) The burden of peritoneal metastases from gastric cancer: a systematic review on the incidence, risk factors and survival. J Clin Med 10(21):4882","journal-title":"J Clin Med"},{"key":"10173_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.650098","volume":"11","author":"O Kranenburg","year":"2021","unstructured":"Kranenburg O, van der Speeten K, de Hingh I (2021) Peritoneal metastases from colorectal cancer: defining and addressing the challenges. Front Oncol 11:650098","journal-title":"Front Oncol"},{"issue":"2","key":"10173_CR9","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1002\/(SICI)1097-0142(20000115)88:2<358::AID-CNCR16>3.0.CO;2-O","volume":"88","author":"B Sadeghi","year":"2000","unstructured":"Sadeghi B, Arvieux C, Glehen O, Beaujard AC, Rivoire M, Baulieux J et al (2000) Peritoneal carcinomatosis from non-gynecologic malignancies. Cancer 88(2):358\u2013363","journal-title":"Cancer"},{"key":"10173_CR10","first-page":"118","volume":"2021","author":"L Toussaint","year":"2021","unstructured":"Toussaint L, Farinha HT, Barras J-L, Demartines N, Sempoux C, H\u00fcbner M (2021) Histological regression of gastrointestinal peritoneal metastases after systemic chemotherapy. Pleura Peritoneum. 2021:118","journal-title":"Pleura Peritoneum."},{"issue":"3","key":"10173_CR11","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1200\/JCO.2011.37.1039","volume":"30","author":"J Franko","year":"2012","unstructured":"Franko J, Shi Q, Goldman CD, Pockaj BA, Nelson GD, Goldberg RM et al (2012) Treatment of colorectal peritoneal carcinomatosis with systemic chemotherapy: a pooled analysis of north central cancer treatment group phase III trials N9741 and N9841. J Clin Oncol 30(3):263\u2013267","journal-title":"J Clin Oncol"},{"issue":"20","key":"10173_CR12","doi-asserted-by":"publisher","first-page":"3737","DOI":"10.1200\/JCO.2003.04.187","volume":"21","author":"VJ Verwaal","year":"2003","unstructured":"Verwaal VJ, Ruth SV, Bree ED, Slooten GW, Tinteren HV, Boot H et al (2003) Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol 21(20):3737\u20133743","journal-title":"J Clin Oncol"},{"issue":"24","key":"10173_CR13","doi-asserted-by":"publisher","first-page":"5608","DOI":"10.1002\/cncr.25356","volume":"116","author":"O Glehen","year":"2010","unstructured":"Glehen O, Gilly FN, Boutitie F, Bereder JM, Quenet F, Sideris L et al (2010) Toward curative treatment of peritoneal carcinomatosis from nonovarian origin by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy. Cancer 116(24):5608\u20135618","journal-title":"Cancer"},{"issue":"2","key":"10173_CR14","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/S1470-2045(20)30599-4","volume":"22","author":"F Qu\u00e9net","year":"2021","unstructured":"Qu\u00e9net F, Elias D, Roca L, Go\u00e9r\u00e9 D, Ghouti L, Pocard M et al (2021) Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol 22(2):256\u2013266","journal-title":"Lancet Oncol"},{"issue":"10","key":"10173_CR15","doi-asserted-by":"publisher","first-page":"2250","DOI":"10.1093\/annonc\/mdq762","volume":"22","author":"YL Klaver","year":"2011","unstructured":"Klaver YL, Lemmens VE, Creemers GJ, Rutten HJ, Nienhuijs SW, de Hingh IH (2011) Population-based survival of patients with peritoneal carcinomatosis from colorectal origin in the era of increasing use of palliative chemotherapy. Ann Oncol 22(10):2250\u20132256","journal-title":"Ann Oncol"},{"issue":"4","key":"10173_CR16","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.ejso.2015.01.018","volume":"41","author":"LG Razenberg","year":"2015","unstructured":"Razenberg LG, van Gestel YR, Creemers GJ, Verwaal VJ, Lemmens VE, de Hingh IH (2015) Trends in cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for the treatment of synchronous peritoneal carcinomatosis of colorectal origin in the Netherlands. Eur J Surg Oncol 41(4):466\u2013471","journal-title":"Eur J Surg Oncol"},{"issue":"3","key":"10173_CR17","doi-asserted-by":"publisher","first-page":"570","DOI":"10.3390\/cancers14030570","volume":"14","author":"BJ Sun","year":"2022","unstructured":"Sun BJ, Lee B (2022) Review of regional therapies for gastric cancer with peritoneal metastases. Cancers 14(3):570","journal-title":"Cancers"},{"issue":"2","key":"10173_CR18","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s10585-021-10074-2","volume":"38","author":"A Brind\u2019Amour","year":"2021","unstructured":"Brind\u2019Amour A, Webb M, Parapini M, Sid\u00e9ris L, Segedi M, Chung SW et al (2021) The role of intraperitoneal chemotherapy in the surgical management of pancreatic ductal adenocarcinoma: a systematic review. Clin Exp Metastasis 38(2):187\u2013196","journal-title":"Clin Exp Metastasis"},{"issue":"6","key":"10173_CR19","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1002\/bjs.10521","volume":"104","author":"F Grass","year":"2017","unstructured":"Grass F, Vuagniaux A, Teixeira-Farinha H, Lehmann K, Demartines N, H\u00fcbner M (2017) Systematic review of pressurized intraperitoneal aerosol chemotherapy for the treatment of advanced peritoneal carcinomatosis. Br J Surg 104(6):669\u2013678","journal-title":"Br J Surg"},{"issue":"3","key":"10173_CR20","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1515\/pp-2017-0018","volume":"2","author":"W Willaert","year":"2017","unstructured":"Willaert W, Sessink P, Ceelen W (2017) Occupational safety of pressurized intraperitoneal aerosol chemotherapy (PIPAC). Pleura Peritoneum 2(3):121\u2013128","journal-title":"Pleura Peritoneum"},{"issue":"12","key":"10173_CR21","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1016\/j.ejso.2019.05.007","volume":"45","author":"O Sgarbura","year":"2019","unstructured":"Sgarbura O, H\u00fcbner M, Alyami M, Eveno C, Gagni\u00e8re J, Pache B et al (2019) Oxaliplatin use in pressurized intraperitoneal aerosol chemotherapy (PIPAC) is safe and effective: a multicenter study. Eur J Surg Oncol 45(12):2386\u20132391","journal-title":"Eur J Surg Oncol"},{"issue":"Suppl 1","key":"10173_CR22","doi-asserted-by":"publisher","first-page":"S259","DOI":"10.21037\/jgo-20-497","volume":"12","author":"RJ Lurvink","year":"2021","unstructured":"Lurvink RJ, Van der Speeten K, Rovers KP, de Hingh I (2021) The emergence of pressurized intraperitoneal aerosol chemotherapy as a palliative treatment option for patients with diffuse peritoneal metastases: a narrative review. J Gastrointest Oncol 12(Suppl 1):S259\u2013S270","journal-title":"J Gastrointest Oncol"},{"issue":"9","key":"10173_CR23","doi-asserted-by":"publisher","first-page":"5311","DOI":"10.1245\/s10434-020-09558-4","volume":"28","author":"KP Rovers","year":"2021","unstructured":"Rovers KP, Wassenaar ECE, Lurvink RJ, Creemers GM, Burger JWA, Los M et al (2021) Pressurized intraperitoneal aerosol chemotherapy (oxaliplatin) for unresectable colorectal peritoneal metastases: a multicenter, single-arm, phase II trial (CRC-PIPAC). Ann Surg Oncol 28(9):5311\u20135326","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10173_CR24","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1007\/s13193-016-0498-0","volume":"7","author":"SJ Valle","year":"2016","unstructured":"Valle SJ, Alzahrani NA, Liauw W, Sugarbaker PH, Bhatt A, Morris DL (2016) Hyperthermic intraperitoneal chemotherapy (HIPEC) methodology, drugs and bidirectional chemotherapy. Indian J Surg Oncol 7(2):152\u2013159","journal-title":"Indian J Surg Oncol"},{"issue":"1","key":"10173_CR25","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","volume":"5","author":"M Ouzzani","year":"2016","unstructured":"Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A (2016) Rayyan-a web and mobile app for systematic reviews. Syst Rev 5(1):210","journal-title":"Syst Rev"},{"key":"10173_CR26","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/1471-2288-14-43","volume":"14","author":"CR Hooijmans","year":"2014","unstructured":"Hooijmans CR, Rovers MM, de Vries RB, Leenaars M, Ritskes-Hoitinga M, Langendam MW (2014) SYRCLE\u2019s risk of bias tool for animal studies. BMC Med Res Methodol 14:43","journal-title":"BMC Med Res Methodol"},{"issue":"1\u20133","key":"10173_CR27","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/S0168-3659(02)00003-2","volume":"80","author":"T Tamura","year":"2002","unstructured":"Tamura T, Fujita F, Tanimoto M, Koike M, Suzuki A, Fujita M et al (2002) Anti-tumor effect of intraperitoneal administration of cisplatin-loaded microspheres to human tumor xenografted nude mice. J Control Release 80(1\u20133):295\u2013307","journal-title":"J Control Release"},{"key":"10173_CR28","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.biomaterials.2016.07.023","volume":"104","author":"L Sim\u00f3n-Gracia","year":"2016","unstructured":"Sim\u00f3n-Gracia L, Hunt H, Scodeller P, Gaitzsch J, Kotamraju VR, Sugahara KN et al (2016) iRGD peptide conjugation potentiates intraperitoneal tumor delivery of paclitaxel with polymersomes. Biomaterials 104:247\u2013257","journal-title":"Biomaterials"},{"issue":"9","key":"10173_CR29","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1007\/s11095-007-9298-0","volume":"24","author":"M Tsai","year":"2007","unstructured":"Tsai M, Lu Z, Wang J, Yeh TK, Wientjes MG, Au JL (2007) Effects of carrier on disposition and antitumor activity of intraperitoneal Paclitaxel. Pharm Res 24(9):1691\u20131701","journal-title":"Pharm Res"},{"issue":"7","key":"10173_CR30","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1111\/j.1349-7006.2012.02274.x","volume":"103","author":"S Emoto","year":"2012","unstructured":"Emoto S, Yamaguchi H, Kishikawa J, Yamashita H, Ishigami H, Kitayama J (2012) Antitumor effect and pharmacokinetics of intraperitoneal NK105, a nanomicellar paclitaxel formulation for peritoneal dissemination. Cancer Sci 103(7):1304\u20131310","journal-title":"Cancer Sci"},{"issue":"10","key":"10173_CR31","doi-asserted-by":"publisher","first-page":"3095","DOI":"10.1039\/c2nr30278k","volume":"4","author":"C Gong","year":"2012","unstructured":"Gong C, Wang C, Wang Y, Wu Q, Zhang D, Luo F et al (2012) Efficient inhibition of colorectal peritoneal carcinomatosis by drug loaded micelles in thermosensitive hydrogel composites. Nanoscale 4(10):3095\u20133104","journal-title":"Nanoscale"},{"key":"10173_CR32","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/j.ijbiomac.2020.02.326","volume":"152","author":"J Luo","year":"2020","unstructured":"Luo J, Wu Z, Lu Y, Xiong K, Wen Q, Zhao L et al (2020) Intraperitoneal administration of biocompatible hyaluronic acid hydrogel containing multi-chemotherapeutic agents for treatment of colorectal peritoneal carcinomatosis. Int J Biol Macromol 152:718\u2013726","journal-title":"Int J Biol Macromol"},{"key":"10173_CR33","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/mabi.201600262","volume":"17","author":"Q Yun","year":"2017","unstructured":"Yun Q, Wang SS, Xu S, Yang JP, Fan J, Yang LL et al (2017) Use of 5-fluorouracil loaded micelles and cisplatin in thermosensitive chitosan hydrogel as an efficient therapy against colorectal peritoneal carcinomatosis. Macromol Biosci 17:4","journal-title":"Macromol Biosci"},{"issue":"11","key":"10173_CR34","doi-asserted-by":"publisher","first-page":"2701","DOI":"10.1002\/ijc.24211","volume":"124","author":"M Keese","year":"2009","unstructured":"Keese M, Gasimova L, Schwenke K, Yagublu V, Shang E, Faissner R et al (2009) Doxorubicin and mitoxantrone drug eluting beads for the treatment of experimental peritoneal carcinomatosis in colorectal cancer. Int J Cancer 124(11):2701\u20132708","journal-title":"Int J Cancer"},{"issue":"1","key":"10173_CR35","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.pan.2012.11.305","volume":"13","author":"V Yagublu","year":"2013","unstructured":"Yagublu V, Caliskan N, Lewis AL, Jesenofsky R, Gasimova L, L\u00f6hr JM et al (2013) Treatment of experimental pancreatic cancer by doxorubicin-, mitoxantrone-, and irinotecan-drug eluting beads. Pancreatology 13(1):79\u201387","journal-title":"Pancreatology"},{"issue":"3","key":"10173_CR36","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.jconrel.2013.09.011","volume":"172","author":"M Tsai","year":"2013","unstructured":"Tsai M, Lu Z, Wientjes MG, Au JL (2013) Paclitaxel-loaded polymeric microparticles: quantitative relationships between in vitro drug release rate and in vivo pharmacodynamics. J Control Release 172(3):737\u2013744","journal-title":"J Control Release"},{"key":"10173_CR37","first-page":"7291","volume":"10","author":"R Fan","year":"2015","unstructured":"Fan R, Tong A, Li X, Gao X, Mei L, Zhou L et al (2015) Enhanced antitumor effects by docetaxel\/LL37-loaded thermosensitive hydrogel nanoparticles in peritoneal carcinomatosis of colorectal cancer. Int J Nanomed 10:7291\u20137305","journal-title":"Int J Nanomed"},{"key":"10173_CR38","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.biomaterials.2018.03.051","volume":"169","author":"K Cherukula","year":"2018","unstructured":"Cherukula K, Bae WK, Lee JH, Park IK (2018) Programmed \u201ctriple-mode\u201d anti-tumor therapy: Improving peritoneal retention, tumor penetration and activatable drug release properties for effective inhibition of peritoneal carcinomatosis. Biomaterials 169:45\u201360","journal-title":"Biomaterials"},{"issue":"1","key":"10173_CR39","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3892\/or.2014.3210","volume":"32","author":"J Kinoshita","year":"2014","unstructured":"Kinoshita J, Fushida S, Tsukada T, Oyama K, Watanabe T, Shoji M et al (2014) Comparative study of the antitumor activity of Nab-paclitaxel and intraperitoneal solvent-based paclitaxel regarding peritoneal metastasis in gastric cancer. Oncol Rep 32(1):89\u201396","journal-title":"Oncol Rep"},{"issue":"4","key":"10173_CR40","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1016\/j.biomaterials.2012.10.077","volume":"34","author":"WK Bae","year":"2013","unstructured":"Bae WK, Park MS, Lee JH, Hwang JE, Shim HJ, Cho SH et al (2013) Docetaxel-loaded thermoresponsive conjugated linoleic acid-incorporated poloxamer hydrogel for the suppression of peritoneal metastasis of gastric cancer. Biomaterials 34(4):1433\u20131441","journal-title":"Biomaterials"},{"issue":"65","key":"10173_CR41","doi-asserted-by":"publisher","first-page":"108848","DOI":"10.18632\/oncotarget.22312","volume":"8","author":"TS Han","year":"2017","unstructured":"Han TS, Hur K, Choi B, Lee JY, Byeon SJ, Min J et al (2017) Improvement of anti-cancer drug efficacy via thermosensitive hydrogel in peritoneal carcinomatosis in gastric cancer. Oncotarget 8(65):108848\u2013108858","journal-title":"Oncotarget"},{"key":"10173_CR42","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1186\/1471-2407-10-402","volume":"10","author":"Y Wang","year":"2010","unstructured":"Wang Y, Gong C, Yang L, Wu Q, Shi S, Shi H et al (2010) 5-FU-hydrogel inhibits colorectal peritoneal carcinomatosis and tumor growth in mice. BMC Cancer 10:402","journal-title":"BMC Cancer"},{"key":"10173_CR43","doi-asserted-by":"publisher","first-page":"28373","DOI":"10.1038\/srep28373","volume":"6","author":"R Fan","year":"2016","unstructured":"Fan R, Li X, Deng J, Gao X, Zhou L, Zheng Y et al (2016) Dual drug loaded biodegradable nanofibrous microsphere for improving anti-colon cancer activity. Sci Rep 6:28373","journal-title":"Sci Rep"},{"key":"10173_CR44","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.ijbiomac.2014.05.026","volume":"69","author":"R Fan","year":"2014","unstructured":"Fan R, Wang Y, Han B, Luo Y, Zhou L, Peng X et al (2014) Docetaxel load biodegradable porous microspheres for the treatment of colorectal peritoneal carcinomatosis. Int J Biol Macromol 69:100\u2013107","journal-title":"Int J Biol Macromol"},{"issue":"5","key":"10173_CR45","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/j.surg.2013.04.054","volume":"154","author":"S Gunji","year":"2013","unstructured":"Gunji S, Obama K, Matsui M, Tabata Y, Sakai Y (2013) A novel drug delivery system of intraperitoneal chemotherapy for peritoneal carcinomatosis using gelatin microspheres incorporating cisplatin. Surgery 154(5):991\u2013999","journal-title":"Surgery"},{"issue":"2","key":"10173_CR46","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1166\/jnn.2011.3403","volume":"11","author":"WK Bae","year":"2011","unstructured":"Bae WK, Lee JH, Lee SJ, Park MS, Hwang JE, Shim HJ et al (2011) Enhanced anti-cancer effect of 5-fluorouracil loaded into thermo-responsive conjugated linoleic acid-incorporated poloxamer hydrogel on metastatic colon cancer models. J Nanosci Nanotechnol 11(2):1425\u20131428","journal-title":"J Nanosci Nanotechnol"},{"key":"10173_CR47","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3390\/ijms20010005","volume":"19","author":"CH Chen","year":"2018","unstructured":"Chen CH, Kuo CY, Chen SH, Mao SH, Chang CY, Shalumon KT et al (2018) Thermosensitive injectable hydrogel for simultaneous intraperitoneal delivery of doxorubicin. Int J Mol Sci 19:5","journal-title":"Int J Mol Sci"},{"key":"10173_CR48","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.ejpb.2016.05.010","volume":"104","author":"S Xu","year":"2016","unstructured":"Xu S, Fan H, Yin L, Zhang J, Dong A, Deng L et al (2016) Thermosensitive hydrogel system assembled by PTX-loaded copolymer nanoparticles for sustained intraperitoneal chemotherapy of peritoneal carcinomatosis. Eur J Pharm Biopharm 104:251\u2013259","journal-title":"Eur J Pharm Biopharm"},{"issue":"2","key":"10173_CR49","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1021\/acsbiomaterials.8b01557","volume":"5","author":"H Qian","year":"2019","unstructured":"Qian H, Qian K, Cai J, Yang Y, Zhu L, Liu B (2019) Therapy for gastric cancer with peritoneal metastasis using injectable albumin hydrogel hybridized with paclitaxel-loaded red blood cell membrane nanoparticles. ACS Biomater Sci Eng 5(2):1100\u20131112","journal-title":"ACS Biomater Sci Eng"},{"issue":"5","key":"10173_CR50","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1007\/s11095-009-0031-z","volume":"27","author":"G Bajaj","year":"2010","unstructured":"Bajaj G, Yeo Y (2010) Drug delivery systems for intraperitoneal therapy. Pharm Res 27(5):735\u2013738","journal-title":"Pharm Res"},{"issue":"5","key":"10173_CR51","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s00280-003-0680-2","volume":"52","author":"F Mohamed","year":"2003","unstructured":"Mohamed F, Marchettini P, Stuart OA, Sugarbaker PH (2003) Pharmacokinetics and tissue distribution of intraperitoneal paclitaxel with different carrier solutions. Cancer Chemother Pharmacol 52(5):405\u2013410","journal-title":"Cancer Chemother Pharmacol"},{"issue":"1","key":"10173_CR52","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/S0022-4804(03)00162-8","volume":"113","author":"F Mohamed","year":"2003","unstructured":"Mohamed F, Stuart OA, Sugarbaker PH (2003) Pharmacokinetics and tissue distribution of intraperitoneal docetaxel with different carrier solutions. J Surg Res 113(1):114\u2013120","journal-title":"J Surg Res"},{"issue":"12 Pt 1","key":"10173_CR53","first-page":"6387","volume":"46","author":"Y Matsumura","year":"1986","unstructured":"Matsumura Y, Maeda H (1986) A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res 46(12 Pt 1):6387\u20136392","journal-title":"Cancer Res"},{"key":"10173_CR54","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s13613-014-0026-8","volume":"4","author":"M Bara","year":"2014","unstructured":"Bara M, Joffe AR (2014) The methodological quality of animal research in critical care: the public face of science. Ann Intensive Care 4:26","journal-title":"Ann Intensive Care"},{"issue":"1","key":"10173_CR55","doi-asserted-by":"publisher","first-page":"11","DOI":"10.4103\/ijp.IJP_536_18","volume":"51","author":"SK Gupta","year":"2019","unstructured":"Gupta SK (2019) A study to assess the methodological quality of in vivo animal experiments published in Indian journal of pharmacology: a retrospective, cross-sectional, observational study. Indian J Pharmacol 51(1):11\u201316","journal-title":"Indian J Pharmacol"},{"issue":"7","key":"10173_CR56","doi-asserted-by":"publisher","first-page":"e3000410","DOI":"10.1371\/journal.pbio.3000410","volume":"18","author":"N Percie du Sert","year":"2020","unstructured":"Percie du Sert N, Hurst V, Ahluwalia A, Alam S, Avey MT, Baker M et al (2020) The ARRIVE guidelines 2.0: updated guidelines for reporting animal research. PLoS Biol 18(7)","journal-title":"PLoS Biol"},{"key":"10173_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fmed.2015.00088","volume":"2","author":"A Derrien","year":"2015","unstructured":"Derrien A, Gouard S, Maurel C, Gaugler M-H, Bruchertseifer F, Morgenstern A et al (2015) Therapeutic efficacy of alpha-RIT using a 213Bi-anti-hCD138 antibody in a mouse model of ovarian peritoneal carcinomatosis. Front Med 2:1","journal-title":"Front Med"},{"issue":"1","key":"10173_CR58","doi-asserted-by":"publisher","first-page":"70","DOI":"10.2174\/15680096113136660110","volume":"14","author":"Z Lu","year":"2014","unstructured":"Lu Z, Tsai M, Wang J, Cole DJ, Wientjes MG, Au JL (2014) Activity of drug-loaded tumor-penetrating microparticles in peritoneal pancreatic tumors. Curr Cancer Drug Targets 14(1):70\u201378","journal-title":"Curr Cancer Drug Targets"},{"issue":"3","key":"10173_CR59","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s00280-019-03767-9","volume":"83","author":"MC Cristea","year":"2019","unstructured":"Cristea MC, Frankel P, Synold T, Rivkin S, Lim D, Chung V et al (2019) A phase I trial of intraperitoneal nab-paclitaxel in the treatment of advanced malignancies primarily confined to the peritoneal cavity. Cancer Chemother Pharmacol 83(3):589\u2013598","journal-title":"Cancer Chemother Pharmacol"},{"issue":"15","key":"10173_CR60","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.1200\/jco.2015.33.15_suppl.2553","volume":"33","author":"MC Cristea","year":"2015","unstructured":"Cristea MC, Synold TW, Frankel PH, Rivkin SE, Lim D, Chung VM et al (2015) Pharmacologic advantage (PA) of intraperitoneal (IP) nab-paclitaxel in patients with advanced malignancies primarily confined to the peritoneal cavity. J Clin Oncol 33(15):2553","journal-title":"J Clin Oncol"},{"key":"10173_CR61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fonc.2021.650098","volume":"11","author":"O Kranenburg","year":"2021","unstructured":"Kranenburg O, Kvd S, Hingh I (2021) Peritoneal metastases from colorectal cancer: defining and addressing the challenges. Front Oncol 11:1","journal-title":"Front Oncol"},{"key":"10173_CR62","first-page":"3","volume":"10","author":"N Christou","year":"2021","unstructured":"Christou N, Auger C, Battu S, Lallou\u00e9 F, Jauberteau-Marchan MO, Hervieu C et al (2021) Intraperitoneal chemotherapy for peritoneal metastases: technical innovations, preclinical and clinical advances and future perspectives. Biology (Basel). 10:3","journal-title":"Biology (Basel)."},{"issue":"1","key":"10173_CR63","first-page":"45","volume":"7","author":"MD Goodman","year":"2015","unstructured":"Goodman MD, McPartland S, Detelich D, Wasif SM (2015) Chemotherapy for intraperitoneal use: a review of hyperthermic intraperitoneal chemotherapy and early post-operative intraperitoneal chemotherapy. J Gastrointest Oncolo 7(1):45\u201357","journal-title":"J Gastrointest Oncolo"},{"issue":"Suppl 1","key":"10173_CR64","first-page":"S40","volume":"20","author":"E de Bree","year":"2015","unstructured":"de Bree E (2015) Optimal drugs for HIPEC in different tumors. J buon 20(Suppl 1):S40\u2013S46","journal-title":"J buon"},{"issue":"2","key":"10173_CR65","first-page":"627","volume":"35","author":"TR Van Oudheusden","year":"2015","unstructured":"Van Oudheusden TR, Grull H, Dankers PY, De Hingh IH (2015) Targeting the peritoneum with novel drug delivery systems in peritoneal carcinomatosis: a review of the literature. Anticancer Res 35(2):627\u2013634","journal-title":"Anticancer Res"},{"issue":"9","key":"10173_CR66","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0043404","volume":"7","author":"G ter Riet","year":"2012","unstructured":"ter Riet G, Korevaar DA, Leenaars M, Sterk PJ, Van Noorden CJ, Bouter LM et al (2012) Publication bias in laboratory animal research: a survey on magnitude, drivers, consequences and potential solutions. PLoS ONE 7(9):e43404","journal-title":"PLoS ONE"},{"issue":"5","key":"10173_CR67","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1093\/ije\/dym174","volume":"36","author":"S Greenland","year":"2007","unstructured":"Greenland S (2007) Commentary: On \u2018Quality in epidemiological research: should we be submitting papers before we have the results and submitting more hypothesis generating research?\u2019 Int J Epidemiol 36(5):944\u2013945","journal-title":"Int J Epidemiol"},{"issue":"5","key":"10173_CR68","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1007\/s00595-013-0674-6","volume":"44","author":"S Emoto","year":"2014","unstructured":"Emoto S, Yamaguchi H, Kamei T, Ishigami H, Suhara T, Suzuki Y et al (2014) Intraperitoneal administration of cisplatin via an in situ cross-linkable hyaluronic acid-based hydrogel for peritoneal dissemination of gastric cancer. Surg Today 44(5):919\u2013926","journal-title":"Surg Today"},{"issue":"9","key":"10173_CR69","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1007\/s00595-019-01792-y","volume":"49","author":"K Yamashita","year":"2019","unstructured":"Yamashita K, Tsunoda S, Gunji S, Murakami T, Suzuki T, Tabata Y et al (2019) Intraperitoneal chemotherapy for peritoneal metastases using sustained release formula of cisplatin-incorporated gelatin hydrogel granules. Surg Today 49(9):785\u2013794","journal-title":"Surg Today"},{"issue":"1","key":"10173_CR70","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10637-010-9499-y","volume":"30","author":"J Yu","year":"2012","unstructured":"Yu J, Lee HJ, Hur K, Kwak MK, Han TS, Kim WH et al (2012) The antitumor effect of a thermosensitive polymeric hydrogel containing paclitaxel in a peritoneal carcinomatosis model. Invest New Drugs 30(1):1\u20137","journal-title":"Invest New Drugs"},{"issue":"5","key":"10173_CR71","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s00280-003-0748-z","volume":"53","author":"K Inoue","year":"2004","unstructured":"Inoue K, Onishi H, Kato Y, Michiura T, Nakai K, Sato M et al (2004) Comparison of intraperitoneal continuous infusion of floxuridine and bolus administration in a peritoneal gastric cancer xenograft model. Cancer Chemother Pharmacol 53(5):415\u2013422","journal-title":"Cancer Chemother Pharmacol"},{"issue":"6","key":"10173_CR72","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0098455","volume":"9","author":"Q Tang","year":"2014","unstructured":"Tang Q, Wang Y, Huang R, You Q, Wang G, Chen Y et al (2014) Preparation of anti-tumor nanoparticle and its inhibition to peritoneal dissemination of colon cancer. PLoS ONE 9(6):e98455","journal-title":"PLoS ONE"},{"issue":"10","key":"10173_CR73","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1111\/j.1349-7006.2009.01265.x","volume":"100","author":"D Soma","year":"2009","unstructured":"Soma D, Kitayama J, Konno T, Ishihara K, Yamada J, Kamei T et al (2009) Intraperitoneal administration of paclitaxel solubilized with poly(2-methacryloxyethyl phosphorylcholine-co n-butyl methacrylate) for peritoneal dissemination of gastric cancer. Cancer Sci 100(10):1979\u20131985","journal-title":"Cancer Sci"},{"issue":"9","key":"10173_CR74","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.2217\/nnm-2015-0023","volume":"11","author":"VL Herrera","year":"2016","unstructured":"Herrera VL, Colby AH, Tan GA, Moran AM, O\u2019Brien MJ, Colson YL et al (2016) Evaluation of expansile nanoparticle tumor localization and efficacy in a cancer stem cell-derived model of pancreatic peritoneal carcinomatosis. Nanomedicine (Lond) 11(9):1001\u20131015","journal-title":"Nanomedicine (Lond)"},{"issue":"4","key":"10173_CR75","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1158\/1535-7163.MCT-15-0713-T","volume":"15","author":"L Sim\u00f3n-Gracia","year":"2016","unstructured":"Sim\u00f3n-Gracia L, Hunt H, Scodeller PD, Gaitzsch J, Braun GB, Willmore AM et al (2016) Paclitaxel-loaded polymersomes for enhanced intraperitoneal chemotherapy. Mol Cancer Ther 15(4):670\u2013679","journal-title":"Mol Cancer Ther"},{"issue":"6","key":"10173_CR76","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/j.nano.2011.10.010","volume":"8","author":"C Gong","year":"2012","unstructured":"Gong C, Yang B, Qian Z, Zhao X, Wu Q, Qi X et al (2012) Improving intraperitoneal chemotherapeutic effect and preventing postsurgical adhesions simultaneously with biodegradable micelles. Nanomedicine 8(6):963\u2013973","journal-title":"Nanomedicine"},{"issue":"1","key":"10173_CR77","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1002\/ijc.10242","volume":"99","author":"H Iinuma","year":"2002","unstructured":"Iinuma H, Maruyama K, Okinaga K, Sasaki K, Sekine T, Ishida O et al (2002) Intracellular targeting therapy of cisplatin-encapsulated transferrin-polyethylene glycol liposome on peritoneal dissemination of gastric cancer. Int J Cancer 99(1):130\u2013137","journal-title":"Int J Cancer"},{"issue":"5","key":"10173_CR78","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1111\/j.1440-1746.2009.06155.x","volume":"25","author":"GP Wang","year":"2010","unstructured":"Wang GP, Guan YS, Jin XR, Jiang SS, Lu ZJ, Wu Y et al (2010) Development of novel 5-fluorouracil carrier erythrocyte with pharmacokinetics and potent antitumor activity in mice bearing malignant ascites. J Gastroenterol Hepatol 25(5):985\u2013990","journal-title":"J Gastroenterol Hepatol"}],"container-title":["Clinical &amp; Experimental Metastasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-022-10173-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10585-022-10173-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-022-10173-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,14]],"date-time":"2022-11-14T18:06:45Z","timestamp":1668449205000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10585-022-10173-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,23]]},"references-count":78,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["10173"],"URL":"https:\/\/doi.org\/10.1007\/s10585-022-10173-8","relation":{},"ISSN":["0262-0898","1573-7276"],"issn-type":[{"value":"0262-0898","type":"print"},{"value":"1573-7276","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,23]]},"assertion":[{"value":"18 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}